A federal judge has dismissed the second amended complaint filed by a nationwide class that had claimed it suffered economic damages from the recall of medicine, including Tylenol, manufactured in a now-closed Fort Washington, Pa., plant operated by a subsidiary of Johnson & Johnson.
None of the 24 named plaintiffs alleged facts sufficient to support standing, U.S. District Judge Mary A. McLaughlin of the Eastern District of Pennsylvania ruled.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]